SCHEMBL7870342

SCHEMBL7870342

CCCCN(CC1CCCCC1)C(=O)Cc1ccc(C(=O)NC(CCSC)C(=O)O)c(-c2ccccc2C)c1.[LiH]

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.73
FNTB P49356 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870340 1.00 FNTA (0.73) FNTAFNTB
SCHEMBL6623577 0.99 FNTA (0.74) FNTAFNTB
SCHEMBL6623575 0.99 FNTA (0.74) FNTAFNTB
SCHEMBL7862383 0.92 FNTA (0.64) FNTAFNTB
SCHEMBL6625798 0.90 FNTA (0.64) FNTAFNTB
SCHEMBL6624535 0.89 FNTA (0.68) FNTAFNTB
SCHEMBL630144 0.88 FNTA (0.78) FNTAFNTB
SCHEMBL6629277 0.87 FNTA (0.79) FNTAFNTB
SCHEMBL8591094 0.86 FNTA (0.73) FNTAFNTB
SCHEMBL7867518 0.85 FNTA (0.69) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310095-B1 INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE UNIVERSITY OF PITTSBURGH 2001-10-30 US disclosed